血清维生素D3作为神经元损伤的潜在生物标志物 在烂的多发性硬化症中
Natalia Niedziela1, Maria Nowak-Kiczmer1, Lina Malciene2
1Department of Neurology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, ul. 3-go Maja 13-15, 41-800 Zabrze, Poland.
International journal of molecular sciences
|October 16, 2024
概括
维生素D缺乏与多发性硬化症 (MS) 患者脑损伤标志物增加有关. 较高的维生素D水平与神经退行指标的降低相关,这表明它有可能成为MS燃烧的生物标志物.
科学领域:
- 神经免疫学 神经免疫学
- 生物化学 生物化学
背景情况:
- 多发性硬化症 (MS) 涉及导致残疾的炎症和神经退行性过程.
- 维生素D (VitD) 在MS神经退行症中的作用尚不清楚.
- 调查维生素D作为燃烧性多发性硬化症中脑损伤的生物标志物至关重要.
研究的目的:
- 评估MS患者血清维生素D水平与特定脑损伤生物标志物之间的关系.
- 为了确定维生素D状态是否会影响复发性复发性多发性硬化 (RRMS) 和渐进性多发性硬化 (PMS) 中的神经退行标志物.
主要方法:
- 评估了神经丝重链 (NF-H),GFAP,S100B和UCHL1.1.的脑脊液 (CSF) 度.
- 与正常维生素D (VitDn) 和维生素D缺乏症 (VitDd) 的MS患者之间的生物标志物水平的比较.
- 在RRMS和PMS队列中分析了血清维生素D水平和CSF生物标志物之间的相关性.
主要成果:
- 与正常维生素D (VitDn) 相比,维生素D缺乏 (VitDd) 与CSF中的NF-H和UCHL1水平较高有关.
- 较高的血清维生素D水平与CSF GFAP,NF-H和S100B在整体MS组和女性中存在负相关性.
- 在男性中观察到血清维生素D和CSF GFAP/NF-H之间的负相关性,但对于S100B和UCHL1.1,没有.
结论:
- 血清维生素D水平和特定的CSF生物标志物显示出潜在的神经退行指标在燃烧的MS.
- 维生素D状态可能会影响多发性硬化症中神经退行性过程的进展.
- 对维生素D作用的进一步研究可能会导致改善多发性硬化症管理策略.
相关概念视频
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...